Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ibuprofen
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : ECI Pharmaceuticals LLC
Deal Size : Undisclosed
Deal Type : Agreement
ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen
Details : According to IQVIA data for the 12 months ended December 2020, total U.S. generic sales of Ibuprofen tablets 400 mg, 600 mg, 800 mg was approximately $110 million. Generic Folic Acid tablets 1 mg were approximately $20 million for the same period.
Brand Name : Ibuprofen-Generic
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 23, 2021
Lead Product(s) : Ibuprofen
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : ECI Pharmaceuticals LLC
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?
Reset All
